Fabrice André, MD, PhD, Gustave Roussy Institute, Villejuif, France, provides an overview of the CANcer TOxicities (CANTO) study, which aims to study the chronic toxicities of cancer treatments, focusing on the cohort of woman with localized breast cancer. So far, approximately 13,000 woman with early stage breast cancer have been included and supported throughout the project. The purpose of CANTO Is to improve the quality of life of woman being treated for locally advanced breast cancer through preventing treatment toxicities. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.